Cookie preferences
We use essential cookies for sign-in and security. With your permission, we also use Plausible Analytics to understand how the site is used. See our Privacy Policy
Angelini Ventures is the venture capital arm of Angelini Industries, investing in innovative startups across biotech and digital health. The firm focuses on advancing healthcare through breakthrough therapies, medical technologies, and data-driven solutions.
With a global investment strategy, Angelini Ventures backs early and growth-stage companies working to improve patient outcomes and transform how diseases are treated and managed. The firm combines capital with deep industry expertise and strategic support from its parent organization.
Angelini Ventures invests in biotech and digital health companies developing innovative therapies, diagnostics, and healthcare technologies. The firm focuses on opportunities that can significantly improve patient outcomes and address unmet medical needs.
Its strategy spans early-stage to growth investments, with a strong emphasis on scientific innovation, clinical validation, and scalable healthcare solutions.

Photo credit: Angelini Ventures
Substantial Capital Commitment
€300 million fund with access to top-tier syndicate network to support portfolio companies through multiple rounds.
Global Expertise & Network
Diverse team with deep healthcare expertise and access to world-leading experts across local ecosystems in Europe and North America.
Enterprise Synergies
Direct access to Angelini Industries for strategic synergies and opportunities, leveraging decades of pharmaceutical and consumer health innovation.
Impact-Focused Approach
Commitment to investing in solutions that advance equitable access to care and address unmet needs in vulnerable populations.
Focus areas